• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    STANDEX REPORTS FISCAL FIRST QUARTER 2026 FINANCIAL RESULTS

    10/30/25 4:01:00 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials
    Get the next $SXI alert in real time by email
    • In Q1 FY26, Sales Increased 27.6% YOY to $217.4 Million; New Products Sales Grew >35% and Sales into Fast Growth Markets Contributed ~30% of Total Sales
    • Q1 FY26 GAAP Operating Margin of 13.6%; Adjusted Operating Margin of 19.1%, Up 210 bps YOY
    • Q1 FY26 Orders of ~$226 Million; Record Quarterly Order Intake
    • Electronics Book to Bill of 1.06; Record Amran/Narayan Group Sales of >$35 Million
    • Paid Down ~$8 Million of Debt in Q1 FY26; Net Debt to EBITDA Ratio Lowered to 2.4x
    • Raising FY26 Sales Outlook to >$110 Million Over FY25; Fast Growth Market Sales to Grow >45% and Exceed $270 Million; Plan to Release >15 New Products, Contributing ~300 bps of Growth

    SALEM, N.H., Oct. 30, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today reported financial results for the first quarter of fiscal year 2026 ended September 30, 2025.

    (PRNewsfoto/Standex International Corp...)

     Summary Financial Results - Total











    ($M except EPS and Dividends)

    1Q26

    1Q25

    4Q25

     Y/Y

    Q/Q

    Net Sales

    $217.4

    $170.5

    $222.0

    27.6 %

    -2.1 %

    Operating Income – GAAP

    $29.6

    $24.1

    $34.7

    23.0 %

    -14.7 %

    Operating Income – Adjusted

    $41.6

    $29.0

    $45.8

    43.3 %

    -9.1 %

    Operating Margin % - GAAP

    13.6 %

    14.1 %

    15.6 %

       - 50 bps

    - 200 bps

    Operating Margin % - Adjusted

    19.1 %

    17.0 %

    20.6 %

    + 210 bps

    - 150 bps

    Net Income from Continuing Ops – GAAP

    $15.8

    $18.2

    $15.5

    -13.0 %

    2.0 %

    Net Income from Continuing Ops – Adjusted

    $24.0

    $21.9

    $27.5

    9.9 %

    -12.7 %













    EBITDA

    $39.7

    $31.2

    $45.2

    27.3 %

    -12.2 %

    EBITDA margin

    18.3 %

    18.3 %

    20.4 %

           0 bps

    - 210 bps

    Adjusted EBITDA

    $47.1

    $34.1

    $51.6

    38.2 %

    -8.6 %

    Adjusted EBITDA margin

    21.7 %

    20.0 %

    23.2 %

    + 170 bps

    - 150 bps













    Diluted EPS – GAAP

    $1.25

    $1.53

    $1.23

    -18.3 %

    1.6 %

    Diluted EPS – Adjusted

    $1.99

    $1.84

    $2.28

    8.2 %

    -12.7 %

    Dividends per Share

    $0.32

    $0.30

    $0.32

    6.7 %

    0.0 %













    Free Cash Flow

    $10.4

    $10.8

    $24.9

    -3.7 %

    -58.2 %













    Net Debt to EBITDA

    2.4x

    (0.1x)

    2.6x

    NM

    -9.9 %

    *Adjusted operating income, adjusted operating margin, and adjusted EPS for all periods now also exclude amortization expense from acquired intangible assets.

    Commenting on the quarter's results, President and Chief Executive Officer David Dunbar said, "Following record operating performance in fiscal year 2025, our fiscal first quarter performance provided a strong start to the fiscal year, positioning us well to surpass our previously provided outlook of greater than $100 million of incremental sales in fiscal year 2026. In the fiscal first quarter, we booked orders of $226 million, the highest quarterly order intake ever. On the top-line, sales increased 27.6% year-on-year to $217.4 million, comprised of a 7% contribution from new products and 30% contribution from sales into fast growth markets. We remain on track for organic growth in fiscal year 2026, primarily driven by new product launches, strong tailwinds in the electrical grid, defense and aviation end markets, and improving general industrial markets. Sales from fast growth markets, such as electrical grid, electric and hybrid vehicles, renewable energy, commercialization of space, and defense, totaled approximately $62 million in the fiscal first quarter and are now expected to exceed $270 million in fiscal year 2026.

    Adjusted gross margin expanded 90 basis points year-on-year to 42.0%, and adjusted operating margin expanded 210 basis points year-on-year to 19.1%. These results reflect the continued evolution of our portfolio and continued focus on pricing disciplines and productivity actions. We paid down approximately $8 million of debt in the fiscal first quarter, and our net leverage ratio was reduced to 2.4x." 

    Fiscal Second Quarter 2026 Outlook

    In fiscal second quarter 2026, on a year-on-year basis, the Company expects significantly higher revenue, driven by mid-single-digit organic growth and the contribution from recent acquisitions, and similar adjusted operating margin due to higher growth investments and less favorable product mix.

    On a sequential basis, the Company expects slightly higher revenue, primarily due to increased contribution from fast growth end markets and new product sales and realization of pricing initiatives. The Company expects slightly lower to similar adjusted operating margin due to increased investments in growth and less favorable product mix.

    Fiscal Year 2026 Outlook

    The Company is raising its fiscal year 2026 sales outlook. In fiscal year 2026, barring any unforeseen economic, global trade, or tariffs related disruptions, the Company now expects revenue to grow by over $110 million, versus the prior outlook calling for revenue to grow by over $100 million. Revenue growth expectations are primarily driven by mid-to-high-single-digit organic growth in Electronics, double-digit organic growth in Engineering Technologies, and the contribution from recent acquisitions. The Company plans to release over fifteen new products that it expects will contribute approximately 300 bps of incremental growth. Sales from fast growth markets are now expected to grow over 45% year-on-year and exceed $270 million. The Company expects continued adjusted operating margin expansion in fiscal year 2026.

    First Quarter Segment Operating Performance

    Electronics (51% of sales; 61% of segment adjusted operating income)



    1Q26

    1Q25

    % Change

    Electronics ($M)







    Revenue

    110.6

    77.7

    42.2 %

    GAAP Operating Income

    28.3

    17.0

    66.1 %

    GAAP Operating Margin %

    25.6

    21.9



    Adjusted Operating Income*

    31.9

    18.4

    73.0 %

    Adjusted Operating Margin %*

    28.8

    23.7





    * Excludes the amortization of acquired intangible assets; Q1 FY25 restated to exclude the amortization of acquired intangible assets

    Revenue increased approximately $32.8 million or 42.2% year-on-year, reflecting a 45.5% benefit from acquisitions, partially offset by an organic decline of 3.1% and a 0.1% impact from foreign currency. Adjusted operating income increased approximately $13.4 million or 73.0% year-on-year due to the contribution from the Amran/Narayan Group acquisition, pricing and productivity initiatives, and product mix. In addition, the Company commenced operations at its greenfield site in Croatia serving electrical grid customers in Europe.

    The segment had a book-to-bill ratio of approximately 1.06 in the fiscal first quarter, with orders of approximately $117 million. Organic orders were approximately $81 million, an increase of 7.6% year-on-year.

    On a sequential basis, the Company expects slightly higher revenue, reflecting higher contribution from the core business, partially offset by lower Amran/Narayan Group sales due to holidays in India. The Company expects similar adjusted operating margin sequentially, primarily driven by product mix and continued strategic growth investments.

    Engineering Technologies (14% of sales; 10% of segment adjusted operating income)



    1Q26

    1Q25

    % Change

    Engineering Technologies ($M)







    Revenue

    29.9

    20.5

    45.6 %

    GAAP Operating Income

    3.6

    4.0

    -9.8 %

    GAAP Operating Margin %

    12.1

    19.5



    Adjusted Operating Income*

    5.0

    4.0

    25.2 %

    Adjusted Operating Margin %*

    16.8

    19.5



    * Excludes the amortization of acquired backlog and acquired intangible assets

    Revenue increased approximately $9.4 million or 45.6% year-on-year reflecting a 32.4% benefit from the McStarlite acquisition, organic growth of 12.7%, and a foreign currency benefit of 0.5%. Organic growth was driven by strong demand across space, defense, and aviation end markets. Adjusted operating income increased approximately $1.0 million or 25.2% year-on-year reflecting the contribution from the recent acquisition and higher volume.

    In fiscal second quarter 2026, on a sequential basis, the Company expects moderately higher revenue due to growth in new product sales and similar adjusted operating margin due to project mix.

    Scientific (9% of sales; 10% of segment adjusted operating income)



    1Q26

    1Q25

    % Change

    Scientific ($M)







    Revenue

    19.5

    17.7

    9.9 %

    GAAP Operating Income

    4.7

    4.7

    -1.5 %

    GAAP Operating Margin %

    24.1

    26.8



    Adjusted Operating Income*

    4.9

    5.0

    -1.7 %

    Adjusted Operating Margin %*

    25.3

    28.3



    * Excludes the amortization of acquired intangible assets; Q1 FY25 restated to exclude the amortization of acquired intangible assets

    Revenue increased approximately $1.8 million or 9.9% year-on-year reflecting an 18.6% benefit from the Custom Biogenic Systems acquisition, partially offset by an organic decline of 8.7% from lower demand at academic and research institutions that were impacted by NIH funding cuts. Adjusted operating income decreased approximately $0.1 million or 1.7% year-on-year due to an organic decline partially offset by contribution from the acquisition.

    In fiscal second quarter 2026, on a sequential basis, the Company expects similar revenue and slightly lower adjusted operating margin due to higher contribution from Custom Biogenic Systems and increased tariff costs.

    Engraving (16% of sales; 13% of segment adjusted operating income)



    1Q26

    1Q25

    % Change

    Engraving ($M)







    Revenue

    35.8

    33.4

    7.4 %

    GAAP Operating Income

    6.5

    5.8

    12.2 %

    GAAP Operating Margin %

    18.2

    17.5



    Adjusted Operating Income*

    6.9

    6.2

    10.6 %

    Adjusted Operating Margin %*

    19.1

    18.6











    * Excludes the amortization of acquired intangible assets; Q1 FY25 restated to exclude the amortization of acquired intangible assets

    Revenue increased approximately $2.5 million or 7.4% year-on-year reflecting organic growth of 5.6% from improved demand in Europe and a foreign currency benefit of 1.9%. Adjusted operating income increased approximately $0.7 million or 10.6% year-on-year due to higher sales and the realization of previously announced productivity initiatives and restructuring actions.

    During the fiscal first quarter, the Company announced the closure of four sites, optimizing the footprint in the United Kingdom, U.S., Italy, and China. These actions are projected to yield approximately $5 million in annualized cost savings once fully implemented, and the Company expects to start realizing savings during the second half of fiscal year 2026. The segment is now substantially done with restructuring activities.

    In fiscal second quarter 2026, on a sequential basis, the Company expects moderately lower revenue and slightly lower adjusted operating margin due to project timing.

    Specialty Solutions (10% of sales; 6% of segment adjusted operating income)



    1Q26

    1Q25

    % Change

    Specialty Solutions ($M)







    Revenue

    21.7

    21.1

    2.6 %

    Operating Income

    2.9

    3.5

    -18.6 %

    Operating Margin %

    13.3

    16.8



    Specialty Solutions revenue increased approximately $0.5 million or 2.6% year-on-year, reflecting slightly improved demand in the Hydraulics business. Operating income decreased approximately $0.7 million or 18.6% year-on-year.

    In fiscal second quarter 2026, on a sequential basis, the Company expects slightly higher revenue and operating margin.

    Capital Allocation

    • Interest: In fiscal second quarter 2026, the Company expects interest expense between $8 million and $8.5 million.
    • Share Repurchase: During the fiscal first quarter of 2026, the Company did not repurchase shares. There was approximately $28 million remaining on the Company's current share repurchase authorization at the end of the fiscal first quarter 2026.
    • Capital Expenditures: In fiscal first quarter 2026, the Company's capital expenditures were $6.4 million compared to $6.7 million in the fiscal first quarter of 2025. The Company expects fiscal year 2026 capital expenditures between $33 million and $38 million. Capital expenditures were $28.3 million in fiscal year 2025. 
    • Dividend: On October 23, 2025, the Company declared a quarterly cash dividend of $0.34 per share, an approximately 6.3% year-on-year increase. The dividend is payable November 21, 2025, to shareholders of record on November 7, 2025.

    Balance Sheet and Cash Flow Highlights

    • Net Debt: Standex had net (cash) debt of $446.0 million on September 30, 2025, compared to ($15.6) million at the end of fiscal first quarter 2025. Net (cash) debt for the first quarter of 2026 consisted primarily of long-term debt of $544.6 million and cash and equivalents of $98.7 million.
    • Cash Flow: Net cash provided by continuing operating activities for the three months ended September 30, 2025, was $16.8 million compared to $17.5 million in the prior year's quarter. Free cash flow after capital expenditures was $10.4 million compared to free cash flow after capital expenditures of $10.8 million in the fiscal first quarter of 2025. 

    Conference Call Details 

    Standex will host a conference call for investors tomorrow, October 31, 2025, at 8:30 a.m. ET. On the call, David Dunbar, President and CEO, and Ademir Sarcevic, CFO, will review the Company's financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located at www.standex.com.

    A replay of the webcast will also be available on the Company's website shortly after the conclusion of the presentation online through October 31, 2026. To listen to the teleconference playback, please dial in the U.S. (888) 660-6345 or (646) 517-4150 internationally; the passcode is 33178#. The audio playback via phone will be available through November 6, 2025. The webcast replay can be accessed in the "Investor Relations" section of the Company's website, located at www.standex.com.

    Use of Non-GAAP Financial Measures

    In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which exclude the impact of restructuring charges, purchase accounting, amortization from acquired intangible assets, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods.  An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect.  Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

    About Standex

    Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. For additional information, visit the Company's website at http://standex.com/.

    Forward-Looking Statements

    Statements contained in this Press Release that are not based on historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as "should," "could," "may," "will," "expect," "believe," "estimate," "anticipate," "intend," "continue," or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company's business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the electrical grid, automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and  compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the "Risk Factors" section of the Company's most recent annual report on Form 10-K filed with the SEC and available on the Company's website. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.

    Standex International Corporation

    Consolidated Statement of Operations

    (unaudited)





















    Three Months Ended







    September 30,

    (In thousands, except per share data)





    2025





    2024















    Net sales



    $

    217,431





    170,464

    Cost of sales





    126,998





    100,391

    Gross profit





    90,433





    70,073















    Selling, general and administrative expenses





    50,129





    41,043

    (Gain) loss on sale of business





    -





    -

    Restructuring costs





    5,997





    1,086

    Amortization of acquired intangible assets





    4,537





    2,005

    Acquisition related costs





    136





    1,840

    Other operating (income) expense, net





    -





    -















    Income from operations





    29,634





    24,099















    Interest expense





    8,912





    977

    Other non-operating (income) expense, net





    (265)





    (28)

    Total





    8,647





    949















    Income from continuing operations before income taxes





    20,987





    23,150

    Provision for income taxes





    5,165





    4,962

    Net income from continuing operations





    15,822





    18,188















    Income (loss) from discontinued operations, net of tax





    (27)





    9















    Net income 





    15,795





    18,197

    Less: net income attributable to redeemable noncontrolling interest





    739





    -

    Net income attributable to Standex International



    $

    15,056





    18,197















    Basic earnings per share:













    Income (loss) from discontinued operations





    -





    -

    Total income (loss) attributable to Standex International



    $

    1.26





    1.54















    Diluted earnings per share:













    Income (loss) from discontinued operations





    -





    -

    Total income (loss) attributable to Standex International



    $

    1.25





    1.53















    Average Shares Outstanding













       Basic





    12,013





    11,787

       Diluted





    12,047





    11,904

     

    Standex International Corporation

    Condensed Consolidated Balance Sheets

    (unaudited)





















    September 30,





    June 30, 

    (In thousands)





    2025





    2025















    ASSETS













    Current assets:













      Cash and cash equivalents



    $

    98,653



    $

    104,542

      Accounts receivable, net





    166,668





    172,702

      Inventories





    135,777





    129,994

      Prepaid expenses and other current assets





    86,475





    73,641

        Total current assets





    487,573





    480,879















    Property, plant, equipment, net





    159,596





    160,364

    Intangible assets, net





    218,164





    225,757

    Goodwill





    599,923





    610,338

    Deferred tax asset





    11,522





    11,971

    Operating lease right-of-use asset





    46,950





    47,998

    Other non-current assets





    31,136





    29,573

        Total non-current assets





    1,067,291





    1,086,001















    Total assets



    $

    1,554,864



    $

    1,566,880















    LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY



















    Current liabilities:













      Accounts payable



    $

    87,704



    $

    88,001

      Accrued liabilities





    66,654





    63,204

      Income taxes payable





    15,339





    15,770

        Total current liabilities





    169,697





    166,975















    Long-term debt





    544,623





    552,515

    Operating lease long-term liabilities





    38,399





    40,057

    Accrued pension and other non-current liabilities





    67,337





    67,743

        Total non-current liabilities





    650,359





    660,315















    Redeemable non-controlling interest





    27,149





    27,913















    Stockholders' equity:













      Common stock





    41,976





    41,976

      Additional paid-in capital





    137,415





    136,082

      Retained earnings





    1,138,071





    1,126,851

      Accumulated other comprehensive loss





    (179,185)





    (164,765)

      Treasury shares





    (430,618)





    (428,467)

         Total stockholders' equity





    707,659





    711,677















    Total liabilities, redeemable noncontrolling interest and stockholders' equity



    $

    1,554,864



    $

    1,566,880

     

    Standex International Corporation and Subsidiaries

    Statements of Consolidated Cash Flows

    (unaudited)







    Three Months Ended







    September 30,

    (In thousands)





    2025



    2024

















    Cash flows from operating activities













    Net income (loss)



    $

    15,795

    $

    18,197



    Income (loss) from discontinued operations





    (27)



    9



    Income from continuing operations





    15,822



    18,188

















    Adjustments to reconcile net income to net cash provided by operating activities:













    Depreciation and amortization





    9,817



    7,061



    Stock-based compensation





    1,774



    2,568



    Non-cash portion of restructuring charge





    149



    (143)



    Contributions to defined benefit plans





    (1,285)



    (3,379)



    Net changes in operating assets and liabilities





    (9,469)



    (6,748)



        Net cash provided by (used in) operating activities - continuing operations





    16,808



    17,547



        Net cash provided by (used in) discontinued operations





    18



    26



        Net cash provided by (used in) operating activities





    16,826



    17,573



    Cash flows from investing activities













        Expenditures for property, plant and equipment





    (6,420)



    (6,725)



        Other investing activities





    59



    411



        Net cash provided by (used in) investing activities - continuing operations





    (6,361)



    (6,314)



        Net cash provided by (used in) investing activities - discontinued operations





    -



    -



        Net cash provided by (used in) investing activities





    (6,361)



    (6,314)



    Cash flows from financing activities













    Payments of debt





    (8,000)



    -



    Distribution to non-controlling interests





    (725)



    -



    Cash dividend paid





    (3,836)



    (3,528)



    Purchase of treasury stock and other





    (4,072)



    (4,381)



    Activity under share-based payment plans





    1,140



    1,637



        Net cash (used in) financing activities





    (15,493)



    (6,273)



    Effect of exchange rate changes on cash and cash equivalents





    (861)



    5,395



        Net change in cash and cash equivalents





    (5,889)



    (10,381)



    Cash and cash equivalents at beginning of period





    104,542



    154,203



    Cash and cash equivalents at end of period



    $

    98,653

    $

    164,584



     

    Standex International Corporation

    Selected Segment Data

    (unaudited)























    Three Months Ended









    September 30,



    (In thousands)





    2025





    2024



    Net Sales















    Electronics



    $

    110,553



    $

    77,733



    Engineering Technologies





    29,894





    20,530



    Scientific





    19,450





    17,693



    Engraving





    35,840





    33,363



    Specialty Solutions





    21,694





    21,145



    Total



    $

    217,431



    $

    170,464



















    Income from operations















    Electronics



    $

    28,283



    $

    17,027



    Engineering Technologies





    3,617





    5,824



    Scientific





    4,678





    4,749



    Engraving





    6,537





    4,010



    Specialty Solutions





    2,889





    3,548



    Gain (loss) on sale of business





    -





    (1,086)



    Restructuring





    (5,997)





    -



    Acquisition related costs





    (136)





    (1,840)



    Corporate





    (10,237)





    (8,133)



    Other operating income (expense), net 





    -





    -



    Total



    $

    29,634



    $

    24,099



     

    Standex International Corporation

    Reconciliation of GAAP to Non-GAAP Financial Measures

    (unaudited)





























    Three Months Ended













    September 30,





    (In thousands, except percentages)





    2025





    2024



    % Change

    Adjusted income from operations and adjusted net income from continuing

    operations:

















    Net Sales



    $

    217,431



    $

    170,464



    27.6 %

    Income from operations, as reported



    $

    29,634



    $

    24,099



    23.0 %



    Income from operations margin





    13.6 %





    14.1 %





    Adjustments:



















    Restructuring charges





    5,997





    1,086







    Acquisition-related costs





    433





    1,840







    Amortization of acquired intangible assets





    4,537





    2,005







    Purchase accounting expenses





    993





    -





    Adjusted income from operations



    $

    41,594



    $

    29,030



    43.3 %



    Adjusted income from operations margin





    19.1 %





    17.0 %







    Interest and other income (expense), net





    (8,647)





    (949)







    Provision for income taxes





    (5,165)





    (4,962)







    Discrete and other tax items





    -





    (72)







    Tax impact of above adjustments





    (3,005)





    (1,183)





    Net income from continuing operations, as adjusted





    24,777





    21,864



    13.3 %



    Less: net income attributable to redeemable noncontrolling interest





    739





    -





    Net income attributable to Standex International, as adjusted



    $

    24,038



    $

    21,864



    9.9 %





















    EBITDA and Adjusted EBITDA:

















    Net income (loss) from continuing operations, as reported



    $

    15,822



    $

    18,188



    -13.0 %



    Net income from continuing operations margin





    7.3 %





    10.7 %





    Add back:



















    Provision for income taxes





    5,165





    4,962







    Interest expense





    8,912





    977







    Depreciation and amortization





    9,817





    7,061





    EBITDA



    $

    39,716



    $

    31,188



    27.3 %



    EBITDA Margin





    18.3 %





    18.3 %





    Adjustments:



















    Restructuring charges





    5,997





    1,086







    Acquisition-related costs





    433





    1,840







    Purchase accounting expenses





    993





    -





    Adjusted EBITDA



    $

    47,139



    $

    34,114



    38.2 %









    21.7 %





    20.0 %

























    Free operating cash flow:

















    Net cash provided by operating activities - continuing operations, as

    reported



    $

    16,808



    $

    17,547





    Less: Capital expenditures





    (6,420)





    (6,725)





    Free cash flow from continuing operations



    $

    10,388



    $

    10,822





     

    Standex International Corporation

    Reconciliation of GAAP to Non-GAAP Financial Measures

    (unaudited)































    Three Months Ended







    Adjusted earnings per share from continuing operations





    September 30,











    2025





    2024



    %

    Change

























    Diluted earnings per share from net income attributable

    to Standex, as reported



    $

    1.25



    $

    1.53



    -18.3 %

























    Adjustments:





















    Restructuring charges





    0.37





    0.07









    Acquisition-related costs





    0.02





    0.12









    Amortization of acquired intangible assets





    0.29





    0.13









    Discrete tax items





    -





    (0.01)









    Purchase accounting expenses





    0.06





    -







    Diluted earnings per share from net income attributeable

    to Standex, as adjusted



    $

    1.99



    $

    1.84



    8.2 %



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/standex-reports-fiscal-first-quarter-2026-financial-results-302600304.html

    SOURCE Standex International Corporation

    Get the next $SXI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SXI

    DatePrice TargetRatingAnalyst
    12/13/2023$165.00Buy
    DA Davidson
    7/18/2023Outperform
    William Blair
    5/2/2023$140.00Outperform
    Barrington Research
    1/27/2023$150.00Buy
    The Benchmark Company
    5/9/2022Mkt Perform → Outperform
    William Blair
    8/16/2021$113.00 → $133.00Outperform
    Barrington Research
    More analyst ratings

    $SXI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP; Chief Information Officer Arets Max bought $12,033 worth of shares (63 units at $191.00), increasing direct ownership by 5% to 1,380 units (SEC Form 4)

    4 - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Issuer)

    2/13/25 3:54:35 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    $SXI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    STANDEX REPORTS FISCAL FIRST QUARTER 2026 FINANCIAL RESULTS

    In Q1 FY26, Sales Increased 27.6% YOY to $217.4 Million; New Products Sales Grew >35% and Sales into Fast Growth Markets Contributed ~30% of Total SalesQ1 FY26 GAAP Operating Margin of 13.6%; Adjusted Operating Margin of 19.1%, Up 210 bps YOYQ1 FY26 Orders of ~$226 Million; Record Quarterly Order IntakeElectronics Book to Bill of 1.06; Record Amran/Narayan Group Sales of >$35 MillionPaid Down ~$8 Million of Debt in Q1 FY26; Net Debt to EBITDA Ratio Lowered to 2.4xRaising FY26 Sales Outlook to >$110 Million Over FY25; Fast Growth Market Sales to Grow >45% and Exceed $270 Million; Plan to Release >15 New Products, Contributing ~300 bps of Growth SALEM, N.H., Oct. 30, 2025 /PRNewswire/ -- Stand

    10/30/25 4:01:00 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    STANDEX ANNOUNCES TIMING OF FIRST QUARTER FISCAL 2026 RESULTS

    SALEM, N.H., Oct. 24, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) will announce its first quarter fiscal 2026 financial results on Thursday, October 30, 2025 after the close of the market and will broadcast its conference call live over the Internet at 8:30 a.m. ET on Friday, October 31, 2025. On the call, David Dunbar, President & CEO, and Ademir Sarcevic, CFO & Treasurer, will review the Company's first quarter financial results, business highlights and outlook. Investors interested in listening to the webcast and viewing the slide presentation should l

    10/24/25 8:30:00 AM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    STANDEX DECLARES 245th CONSECUTIVE QUARTERLY DIVIDEND

    SALEM, N.H., Oct. 23, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced that its Board of Directors has declared a quarterly cash dividend of $0.34 per share, an approximately 6.3% year-on-year increase. The dividend is payable November 21, 2025, to shareholders of record on November 7, 2025.  The dividend is the Company's 245th consecutive quarterly cash dividend. Standex has paid dividends each quarter since it became a public corporation in November 1964. About Standex Standex International Corporation is a global multi-industry manufacturer

    10/23/25 8:57:00 AM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    $SXI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson initiated coverage on Standex International with a new price target

    DA Davidson initiated coverage of Standex International with a rating of Buy and set a new price target of $165.00

    12/13/23 7:53:39 AM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    William Blair resumed coverage on Standex International

    William Blair resumed coverage of Standex International with a rating of Outperform

    7/18/23 7:27:14 AM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    Barrington Research resumed coverage on Standex International with a new price target

    Barrington Research resumed coverage of Standex International with a rating of Outperform and set a new price target of $140.00

    5/2/23 10:09:07 AM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    $SXI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Kshirsagar Vineet claimed ownership of 5,697 shares (SEC Form 3)

    3 - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Issuer)

    10/31/25 5:24:51 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    VP, Chief HR Officer Bell Annemarie covered exercise/tax liability with 111 shares, decreasing direct ownership by 1% to 7,311 units (SEC Form 4)

    4 - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Issuer)

    10/27/25 3:49:15 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    Director Chorman Thomas E was granted 639 shares, increasing direct ownership by 5% to 14,229 units (SEC Form 4)

    4 - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Issuer)

    10/22/25 3:45:35 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    $SXI
    SEC Filings

    View All

    Standex International Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Filer)

    10/31/25 4:26:16 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by Standex International Corporation

    10-Q - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Filer)

    10/31/25 4:18:14 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    Standex International Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Filer)

    10/31/25 1:47:03 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    $SXI
    Leadership Updates

    Live Leadership Updates

    View All

    STANDEX ACQUIRES MCSTARLITE

    SALEM, N.H., Feb. 5, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced that it has acquired privately-held, California-based McStarlite Co., a leading provider of complex sheet metal aerospace components, for approximately $56.5 million in cash, financed from Standex's existing revolver. In its first year of ownership, the Company expects the acquisition to be accretive to its earnings. McStarlite Co. will be reported as part of Standex's Engineering Technologies Group business segment. In calendar year 2024, McStarlite revenue was approximately $33 million with an adjusted EBITDA margin above 20%. 

    2/5/25 4:01:00 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    STANDEX APPOINTS CHRISTOPHER HOWE AS DIRECTOR OF INVESTOR RELATIONS

    SALEM, N.H., Oct. 17, 2022 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced the appointment of Christopher Howe to the position of Standex Director of Investor Relations, effective October 12, 2022. Howe is a seasoned equity analyst with almost a decade of experience covering diversified industrials and industrial technology companies. He holds an M.B.A in financial analysis from DePaul University's Kellstadt Graduate School of Business, where he graduated with distinction. As Standex Director of Investor Relations, Howe will be responsible for mana

    10/17/22 4:15:00 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    Parker Announces Retirement of Vice President - Corporate Finance Robin J. Davenport

    CLEVELAND, May 03, 2022 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today announced that Robin J. Davenport, Vice President - Corporate Finance, will retire effective December 31, 2022, after 19 years of dedicated service to the company.  "Robin should take pride in all she has accomplished throughout her career and nearly two decades with Parker," said Todd Leombruno, Executive Vice President and Chief Financial Officer. "As a corporate finance leader, Robin not only served as Parker's primary contact to the investment community but helped lead the company through several phases of growth and expansion, navigate perio

    5/3/22 5:00:00 PM ET
    $PH
    $SXI
    Metal Fabrications
    Industrials
    Industrial Machinery/Components

    $SXI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Standex International Corporation

    SC 13G - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Subject)

    2/14/24 4:12:33 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Standex International Corporation (Amendment)

    SC 13G/A - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Subject)

    2/13/24 5:14:04 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Standex International Corporation (Amendment)

    SC 13G/A - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Subject)

    2/13/24 3:11:32 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    $SXI
    Financials

    Live finance-specific insights

    View All

    STANDEX REPORTS FISCAL FIRST QUARTER 2026 FINANCIAL RESULTS

    In Q1 FY26, Sales Increased 27.6% YOY to $217.4 Million; New Products Sales Grew >35% and Sales into Fast Growth Markets Contributed ~30% of Total SalesQ1 FY26 GAAP Operating Margin of 13.6%; Adjusted Operating Margin of 19.1%, Up 210 bps YOYQ1 FY26 Orders of ~$226 Million; Record Quarterly Order IntakeElectronics Book to Bill of 1.06; Record Amran/Narayan Group Sales of >$35 MillionPaid Down ~$8 Million of Debt in Q1 FY26; Net Debt to EBITDA Ratio Lowered to 2.4xRaising FY26 Sales Outlook to >$110 Million Over FY25; Fast Growth Market Sales to Grow >45% and Exceed $270 Million; Plan to Release >15 New Products, Contributing ~300 bps of Growth SALEM, N.H., Oct. 30, 2025 /PRNewswire/ -- Stand

    10/30/25 4:01:00 PM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    STANDEX ANNOUNCES TIMING OF FIRST QUARTER FISCAL 2026 RESULTS

    SALEM, N.H., Oct. 24, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) will announce its first quarter fiscal 2026 financial results on Thursday, October 30, 2025 after the close of the market and will broadcast its conference call live over the Internet at 8:30 a.m. ET on Friday, October 31, 2025. On the call, David Dunbar, President & CEO, and Ademir Sarcevic, CFO & Treasurer, will review the Company's first quarter financial results, business highlights and outlook. Investors interested in listening to the webcast and viewing the slide presentation should l

    10/24/25 8:30:00 AM ET
    $SXI
    Industrial Machinery/Components
    Industrials

    STANDEX DECLARES 245th CONSECUTIVE QUARTERLY DIVIDEND

    SALEM, N.H., Oct. 23, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced that its Board of Directors has declared a quarterly cash dividend of $0.34 per share, an approximately 6.3% year-on-year increase. The dividend is payable November 21, 2025, to shareholders of record on November 7, 2025.  The dividend is the Company's 245th consecutive quarterly cash dividend. Standex has paid dividends each quarter since it became a public corporation in November 1964. About Standex Standex International Corporation is a global multi-industry manufacturer

    10/23/25 8:57:00 AM ET
    $SXI
    Industrial Machinery/Components
    Industrials